← Back to patent-cliff list
Atropine
Tier C — Watch / tradeAtropine
Cloudbreak Therapeutics Llc
Originator
1973
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：mAChRs
Indications (approved)：近视, 变性近视, 中毒
Regional status
US
Phase III
2023-10-07
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Atropine?
Approved indications include: 近视, 变性近视, 中毒.
When does the Atropine patent expire?
No public expiry year is available for Atropine yet; this page updates once verified.
How do I get a quote for Atropine intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-02